A more dramatic scenario exists in children with high-risk NB at diagnosis, which includes stage 4 patients <18 months with MYCN amplification or >18 months with or without MYCN amplification and rare patients with MYCN-amplified localized tumors (3, 5). Here, MYCN is linked to neuroblastoma.